Jim B. Robbins

This profile gathers the share dealings of Jim B. Robbins across 2 companies, led by Micrus Endovascular Corp and Viveve Medical, Inc. Between 30 June 2007 and 15 December 2021, the trades on record add up to 16 filings.

Both buying and selling appear: 1 purchase worth €22k, against 3 sales worth €84k. On balance, insiders were net sellers of €62k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants and 4 option exercises.

The record was last updated on 17 December 2021 with a transaction (€46) in Viveve Medical, Inc. The last insider purchase was made public on 14 May 2015, 4,184 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.